Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Jan;27(1):49–56. doi: 10.1111/j.1365-2125.1989.tb05334.x

Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.

L Borgström 1, L Nyberg 1, S Jönsson 1, C Lindberg 1, J Paulson 1
PMCID: PMC1379704  PMID: 2706188

Abstract

1. The pharmacokinetics of the two enantiomers of terbutaline, (+)T and (-)T, and the racemate (+/-)T, have been evaluated after single intravenous and oral dosage to six healthy volunteers. 2. The mean systemic clearance, CL, was 0.19 and 0.13 l h-1 kg-1 for (+)T and (-)T, respectively. This difference was statistically significant. The mean clearance of (+/-)T was 0.20 l h-1 kg-1. Volumes of distribution were similar (1.9 l kg-1) after the three intravenous administrations. The differences in CL were reflected in values of the elimination half-life and MRT. 3. The difference in CL of the isomers could be explained by a corresponding difference in their renal clearance, CLR. Competition for stereoselective active reabsorption in the tubule might explain why (+)T seemed to enhance the CLR of (-)T when the drug was given as the racemate. 4. Oral bioavailability, calculated from plasma data, of (+)T was 7.5% and that of (-)T was 14.8%. This difference was statistically significant and was mainly due to a difference in absorption of (+)T and (-)T, but also to a difference in their subsequent first-pass metabolism. The bioavailability of (+/-)T was similar to that of (-)T. 5. (-)T appears to govern the absorption properties of the racemate, while (+)T determines its elimination behaviour. Systemic metabolism of the two enantiomers was similar and, therefore, a greater first-pass metabolism of (+)T would reflect a higher capacity of the gut wall to metabolise this isomer.

Full text

PDF
49

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ariëns E. J. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol. 1984;26(6):663–668. doi: 10.1007/BF00541922. [DOI] [PubMed] [Google Scholar]
  2. Balant L., Muir K., Dayer P., Gorgia A., Eberlin J. L., Estreicher J., Fabre J. Simultaneous tubular excretion and reabsorption of pindolol in man. Eur J Clin Pharmacol. 1981;21(1):65–72. doi: 10.1007/BF00609590. [DOI] [PubMed] [Google Scholar]
  3. Borgström L., Johansson C. G., Larsson H., Lenander R. Pharmacokinetics of bendroflumethiazide after low oral doses. J Pharmacokinet Biopharm. 1981 Aug;9(4):431–441. doi: 10.1007/BF01060887. [DOI] [PubMed] [Google Scholar]
  4. Davies D. S. Pharmacokinetics of terbutaline after oral administration. Eur J Respir Dis Suppl. 1984;134:111–117. [PubMed] [Google Scholar]
  5. Eichelbaum M., Mikus G., Vogelgesang B. Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration. Br J Clin Pharmacol. 1984 Apr;17(4):453–458. doi: 10.1111/j.1365-2125.1984.tb02371.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Godbillon J., Richard J., Gerardin A., Meinertz T., Kasper W., Jähnchen E. Pharmacokinetics of the enantiomers of acenocoumarol in man. Br J Clin Pharmacol. 1981 Nov;12(5):621–629. doi: 10.1111/j.1365-2125.1981.tb01280.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hsyu P. H., Giacomini K. M. Stereoselective renal clearance of pindolol in humans. J Clin Invest. 1985 Nov;76(5):1720–1726. doi: 10.1172/JCI112161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hultquist C., Lindberg C., Nyberg L., Kjellman B., Wettrell G. Kinetics of terbutaline in asthmatic children. Eur J Respir Dis Suppl. 1984;134:195–203. [PubMed] [Google Scholar]
  9. Jacobsson S. E., Jönsson S., Lindberg C., Svensson L. A. Determination of terbutaline in plasma by gas chromatography chemical ionization mass spectrometry. Biomed Mass Spectrom. 1980 Jun;7(6):265–268. doi: 10.1002/bms.1200070608. [DOI] [PubMed] [Google Scholar]
  10. Jeppsson A. B., Johansson U., Waldeck B. Steric aspects of agonism and antagonism at beta-adrenoceptors: experiments with the enantiomers of terbutaline and pindolol. Acta Pharmacol Toxicol (Copenh) 1984 Apr;54(4):285–291. doi: 10.1111/j.1600-0773.1984.tb01932.x. [DOI] [PubMed] [Google Scholar]
  11. Lee E. J., Williams K., Day R., Graham G., Champion D. Stereoselective disposition of ibuprofen enantiomers in man. Br J Clin Pharmacol. 1985 May;19(5):669–674. doi: 10.1111/j.1365-2125.1985.tb02694.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Nakamura J., Takamura R., Kimura T., Muranishi S., Sezaki H. Enhancement effect of methylxanthines on the intestinal absorption of poorly absorbable dyes from the rat small intestine. Biochem Pharmacol. 1979 Oct 1;28(19):2957–2960. doi: 10.1016/0006-2952(79)90592-6. [DOI] [PubMed] [Google Scholar]
  13. Notterman D. A., Drayer D. E., Metakis L., Reidenberg M. M. Stereoselective renal tubular secretion of quinidine and quinine. Clin Pharmacol Ther. 1986 Nov;40(5):511–517. doi: 10.1038/clpt.1986.216. [DOI] [PubMed] [Google Scholar]
  14. Nyberg L., Kennedy B. M. Pharmacokinetics of terbutaline given in slow-release tablets. Eur J Respir Dis Suppl. 1984;134:119–139. [PubMed] [Google Scholar]
  15. Nyberg L. Pharmacokinetic parameters of terbutaline in healthy man. An overview. Eur J Respir Dis Suppl. 1984;134:149–160. [PubMed] [Google Scholar]
  16. Olanoff L. S., Walle T., Walle U. K., Cowart T. D., Gaffney T. E. Stereoselective clearance and distribution of intravenous propranolol. Clin Pharmacol Ther. 1984 Jun;35(6):755–761. doi: 10.1038/clpt.1984.107. [DOI] [PubMed] [Google Scholar]
  17. Quebbemann A. J., Rennick B. R. Effects of structural modifications of catecholamines on renal tubular transport in the chicken. J Pharmacol Exp Ther. 1969 Mar;166(1):52–62. [PubMed] [Google Scholar]
  18. Rennick B. R. Renal tubule transport of organic cations. Am J Physiol. 1981 Feb;240(2):F83–F89. doi: 10.1152/ajprenal.1981.240.2.F83. [DOI] [PubMed] [Google Scholar]
  19. Ross C. R., Holohan P. D. Transport of organic anions and cations in isolated renal plasma membranes. Annu Rev Pharmacol Toxicol. 1983;23:65–85. doi: 10.1146/annurev.pa.23.040183.000433. [DOI] [PubMed] [Google Scholar]
  20. Ryrfeldt A., Ramsay C. H. Distribution of terbutaline. Eur J Respir Dis Suppl. 1984;134:63–72. [PubMed] [Google Scholar]
  21. Tegnér K., Nilsson H. T., Persson C. G., Persson K., Ryrfeldt A. Elimination pathways of terbutaline. Eur J Respir Dis Suppl. 1984;134:93–100. [PubMed] [Google Scholar]
  22. Vogelgesang B., Echizen H., Schmidt E., Eichelbaum M. Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique. Br J Clin Pharmacol. 1984 Nov;18(5):733–740. doi: 10.1111/j.1365-2125.1984.tb02536.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Von Bahr C., Hermansson J., Tawara K. Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man. Br J Clin Pharmacol. 1982 Jul;14(1):79–82. doi: 10.1111/j.1365-2125.1982.tb04937.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wetterlin K. Resolution of terbutaline, a new -sympathomimetic amine. J Med Chem. 1972 Nov;15(11):1182–1183. doi: 10.1021/jm00281a025. [DOI] [PubMed] [Google Scholar]
  25. Wu D. F., Yu Y. W., Tang Z. M., Wang M. Z. Pharmacokinetics of (+/-)-, (+)-, and (-)-gossypol in humans and dogs. Clin Pharmacol Ther. 1986 Jun;39(6):613–618. doi: 10.1038/clpt.1986.108. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES